Lawyers for Ovarian Cancer Victims Call on Regulators to Stop 'Contemptible' Johnson & Johnson Bankruptcy Plan

Attorneys representing several thousand women diagnosed with ovarian cancer after exposure to Johnson & Johnson (NYSE: JNJ) Baby Powder and other talc-based products are denouncing the company over reports it is considering bankruptcy to avoid financial responsibility.

"This is about as contemptible as it gets," says attorney Leigh O'Dell of Beasley Allen , co-lead counsel of the plaintiff's steering committee in federal multidistrict litigation (MDL) in New Jersey . "These women have suffered enough. If this report is true, we believe it's time for Congress and the Securities and Exchange Commission to investigate and outlaw cash-rich companies from playing corporate shell games and using federal bankruptcy law to avoid paying the victims they've hurt and misled."

According to a July 28 report by the Reuters news agency, " Exclusive: J&J exploring putting talc liabilities into bankruptcy - sources," the company, which enjoys a $443 billion market capitalization, is considering bankruptcy to limit financial exposure to thousands of lawsuits related to its talc-based products, including Johnson's Baby Powder and Shower to Shower brands.

Dozens of studies published in peer-reviewed journals during the past 25 years have shown a statistically significant association between talc use and ovarian cancer. Documents produced at trial show that the company was aware of the possible dangers as far back as the 1960s.

Since 2013, juries in numerous trials have found J&J liable for compensatory and punitive damages to ovarian cancer victims, although many verdicts were later overturned in appellate courts on jurisdictional grounds, but not on the merits of the case.

Last year, a Missouri appellate court entered a $2.1 billion judgment against the company. Justices found "significant reprehensibility" in J&J's handling of the issue of asbestos in its baby powder and concluded that J&J avoided "adopting more accurate measures for detecting asbestos," while discussing the asbestos risk of the powder in internal memos and refusing until recently to replace talc in its baby powder with corn starch, which doesn't pose a cancer risk.

Both the Missouri Supreme Court and the United States Supreme Court declined to overturn the award. A bankruptcy filing could significantly reduce the compensation available to remaining claimants and would prevent them from having their day in court.

"Solvent corporations should not be able to abuse the bankruptcy process to shield themselves from their responsibilities," says trial lawyer Michelle Parfitt , co-lead counsel in the federal talc MDL and a senior partner in the law firm, Ashcraft & Gerel. "This would be corporate welfare of the worst kind. And who would suffer the most? The women who have already lost so much due to J&J's behavior. I believe they are attempting to intimidate them by threatening bankruptcy. It won't work."

About the Beasley Allen Law Firm
Headquartered in Montgomery, Ala. , Beasley Allen is comprised of more than 70 attorneys and 200 support staff. One of the largest Plaintiffs law firms in the country, Beasley Allen is a national leader in civil litigation, with verdicts and settlements in excess of $26 billion . For more information visit www.beasleyallen.com .

Contact:

Mike Androvett
Androvett Legal Media
800-559-4534

Cision View original content: https://www.prnewswire.com/news-releases/lawyers-for-ovarian-cancer-victims-call-on-regulators-to-stop-contemptible-johnson--johnson-bankruptcy-plan-301336142.html

SOURCE Beasley Allen Law Firm

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News